NCT06947811
- Conditions
- EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
Explore clinical trials studying EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study